Treatment with interferon-α for metastatic renal cell cancer

Y. Shirasaki, T. Tsushima, T. Kurashige, N. Kusaka, R. Arata, H. Kaku, T. Saika, Yasutomo Nasu, H. Kumon

Research output: Contribution to journalArticle

Abstract

We examined 51 patients treated with interferon-α for metastatic renal cell cancer. The results comprised complete response (CR) in no patients, partial response (PR) in 6 patients, no change (NC) in 34 and progression of disease (PD) in 11. The overall response rate was 11.8%. All of the responders had lung metastasis. One-, three- and five-year survival rates were 63.7%, 21.5% and 12.5%, respectively. There were 5 long-term survivors in the NC group who showed survival times in excess of 5 years, who had undergone radical nephrectomy because of good performance status.

Original languageEnglish
Pages (from-to)344-346
Number of pages3
JournalNishinihon Journal of Urology
Volume63
Issue number5
Publication statusPublished - 2001

Fingerprint

Renal Cell Carcinoma
Interferons
Nephrectomy
Survivors
Disease Progression
Therapeutics
Survival Rate
Neoplasm Metastasis
Lung
Survival

Keywords

  • Interferon
  • Renal cell cancer

ASJC Scopus subject areas

  • Urology

Cite this

Shirasaki, Y., Tsushima, T., Kurashige, T., Kusaka, N., Arata, R., Kaku, H., ... Kumon, H. (2001). Treatment with interferon-α for metastatic renal cell cancer. Nishinihon Journal of Urology, 63(5), 344-346.

Treatment with interferon-α for metastatic renal cell cancer. / Shirasaki, Y.; Tsushima, T.; Kurashige, T.; Kusaka, N.; Arata, R.; Kaku, H.; Saika, T.; Nasu, Yasutomo; Kumon, H.

In: Nishinihon Journal of Urology, Vol. 63, No. 5, 2001, p. 344-346.

Research output: Contribution to journalArticle

Shirasaki, Y, Tsushima, T, Kurashige, T, Kusaka, N, Arata, R, Kaku, H, Saika, T, Nasu, Y & Kumon, H 2001, 'Treatment with interferon-α for metastatic renal cell cancer', Nishinihon Journal of Urology, vol. 63, no. 5, pp. 344-346.
Shirasaki Y, Tsushima T, Kurashige T, Kusaka N, Arata R, Kaku H et al. Treatment with interferon-α for metastatic renal cell cancer. Nishinihon Journal of Urology. 2001;63(5):344-346.
Shirasaki, Y. ; Tsushima, T. ; Kurashige, T. ; Kusaka, N. ; Arata, R. ; Kaku, H. ; Saika, T. ; Nasu, Yasutomo ; Kumon, H. / Treatment with interferon-α for metastatic renal cell cancer. In: Nishinihon Journal of Urology. 2001 ; Vol. 63, No. 5. pp. 344-346.
@article{dc0908af5a0848a98e1cfd8559eb02f3,
title = "Treatment with interferon-α for metastatic renal cell cancer",
abstract = "We examined 51 patients treated with interferon-α for metastatic renal cell cancer. The results comprised complete response (CR) in no patients, partial response (PR) in 6 patients, no change (NC) in 34 and progression of disease (PD) in 11. The overall response rate was 11.8{\%}. All of the responders had lung metastasis. One-, three- and five-year survival rates were 63.7{\%}, 21.5{\%} and 12.5{\%}, respectively. There were 5 long-term survivors in the NC group who showed survival times in excess of 5 years, who had undergone radical nephrectomy because of good performance status.",
keywords = "Interferon, Renal cell cancer",
author = "Y. Shirasaki and T. Tsushima and T. Kurashige and N. Kusaka and R. Arata and H. Kaku and T. Saika and Yasutomo Nasu and H. Kumon",
year = "2001",
language = "English",
volume = "63",
pages = "344--346",
journal = "Nishinihon Journal of Urology",
issn = "0029-0726",
publisher = "Kyushu University, Faculty of Science",
number = "5",

}

TY - JOUR

T1 - Treatment with interferon-α for metastatic renal cell cancer

AU - Shirasaki, Y.

AU - Tsushima, T.

AU - Kurashige, T.

AU - Kusaka, N.

AU - Arata, R.

AU - Kaku, H.

AU - Saika, T.

AU - Nasu, Yasutomo

AU - Kumon, H.

PY - 2001

Y1 - 2001

N2 - We examined 51 patients treated with interferon-α for metastatic renal cell cancer. The results comprised complete response (CR) in no patients, partial response (PR) in 6 patients, no change (NC) in 34 and progression of disease (PD) in 11. The overall response rate was 11.8%. All of the responders had lung metastasis. One-, three- and five-year survival rates were 63.7%, 21.5% and 12.5%, respectively. There were 5 long-term survivors in the NC group who showed survival times in excess of 5 years, who had undergone radical nephrectomy because of good performance status.

AB - We examined 51 patients treated with interferon-α for metastatic renal cell cancer. The results comprised complete response (CR) in no patients, partial response (PR) in 6 patients, no change (NC) in 34 and progression of disease (PD) in 11. The overall response rate was 11.8%. All of the responders had lung metastasis. One-, three- and five-year survival rates were 63.7%, 21.5% and 12.5%, respectively. There were 5 long-term survivors in the NC group who showed survival times in excess of 5 years, who had undergone radical nephrectomy because of good performance status.

KW - Interferon

KW - Renal cell cancer

UR - http://www.scopus.com/inward/record.url?scp=0035006030&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035006030&partnerID=8YFLogxK

M3 - Article

VL - 63

SP - 344

EP - 346

JO - Nishinihon Journal of Urology

JF - Nishinihon Journal of Urology

SN - 0029-0726

IS - 5

ER -